Journament

Keyword Connections - alzheimer's disease Keywords

Connection Type	Connection
Journals	European journal of medicinal chemistry Bioorganic chemistry Scientific reports Heliyon Journal of food biochemistry Neuropharmacology International journal of biological macromolecules Behavioural brain research Medicine Theranostics contemporary clinical trials communications medicinal research reviews Environmental research Frontiers in bioengineering and biotechnology computational and structural biotechnology journal alzheimer's & dementia (new york, n y) neurobiology of aging IEEE Transactions on Neural Networks and Learning Systems alzheimer's & dementia (amsterdam, netherlands) international journal of nursing studies NeuroImage The Journal of neuroscience : the official journal of the Society for Neuroscience the journal of pediatrics Frontiers in neuroscience Journal of the American Geriatrics Society mayo clinic proceedings Clinical radiology urologic oncology geriatrie et psychologie neuropsychiatrie du vieillissement frontiers in neurology pharmacology research & perspectives international journal of radiation oncology, biology, physics Journal of the neurological sciences Medical image analysis international journal of language & communication disorders the annals of thoracic surgery drug development research current alzheimer research journal of the american medical directors association European journal of neurology Alzheimer's & dementia : the journal of the Alzheimer's Association child development soins gerontologie journal of thyroid research
Research Groups	No Research Group Connected
Bibliographies	[1] Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adults. [2] [Understanding the suffering of the elderly]. [3] Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent. [4] Nutrition, Growth, Brain Volume, and Neurodevelopment in Very Preterm Children. [5] Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume. [6] Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase. [7] The case-finding study: A novel community-based research recruitment approach for engaging participants with early cognitive decline. [8] Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease. [9] Energy Disaggregation via Deep Temporal Dictionary Learning. [10] Passive Digital Signature for Early Identification of Alzheimer's Disease and Related Dementia. [11] Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy. [12] Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain Atrophy. [13] TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): Protocol for a systematic review and network meta-analysis. [14] Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease. [15] Biomaterials and Advanced Biofabrication Techniques in hiPSCs Based Neuromyopathic Disease Modeling. [16] Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-β structure based virtual screening. [17] A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy. [18] Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease. [19] Study of Vitamin D Level and Vitamin D Receptor Polymorphism in Hypothyroid Egyptian Patients. [20] Replay by authors: Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer. [21] Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration. [22] Quercetin reduces eIF2α phosphorylation by GADD34 induction. [23] Probing the interaction of Rivastigmine Tartrate, an important Alzheimer's drug, with serum albumin: Attempting treatment of Alzheimer's disease. [24] Cardiopulmonary Bypass: How I Teach It. [25] Rho-kinase ROCK inhibitors reduce oligomeric tau protein. [26] Endothelial Vascular Function as a Surrogate of Vascular Risk and Aging in Women. [27] Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388. [28] Discourse macrolinguistic impairment as a marker of linguistic and extralinguistic functions decline in early Alzheimer's disease. [29] Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer's Disease. [30] Aligning Requirements of Training and Assessment in Radiation Treatment Planning in the Era of Competency-Based Medical Education. [31] Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. [32] Young Children's Mathematical Learning From Intelligent Characters. [33] Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution. [34] Oral treatment with royal jelly improves memory and presents neuroprotective effects on icv-STZ rat model of sporadic Alzheimer's disease. [35] Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses. [36] A training program for primary health care nurses on timely diagnosis and management of dementia in general practice: An evaluation study. [37] Evaluating the Efficacy of a Web-Based Program (Diapason) for Informal Caregivers of Patients With Alzheimer’s Disease: Protocol for a Randomized Clinical Trial [38] A Web-Based Program for Informal Caregivers of Persons With Alzheimer’s Disease: An Iterative User-Centered Design [39] Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. [40] Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease. [41] scorpion venom heat-resistant peptide protects transgenic caenorhabditis elegans from β- amyloid toxicity [42] associative agreement as a predictor of naming ability in alzheimer's disease: a case for the semantic nature of associative links [43] modulation of brain activity with noninvasive transcranial direct current stimulation (tdcs): clinical applications and safety concerns [44] crispr/cas9 mediated disruption of the swedish app allele as a therapeutic approach for early-onset alzheimer’s disease [45] mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic alzheimer's disease [46] adnp: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration [47] dna demethylation upregulated nrf2 expression in alzheimer's disease cellular model [48] novel therapies for treatment of alzheimers disease [49] deep brain stimulation as a tool for improving cognitive functioning in alzheimer’s dementia: a systematic review [50] fast parallel image registration on cpu and gpu for diagnostic classification of alzheimer's disease [51] the potential of epigenetic therapies in neurodegenerative diseases [52] mitochondrial protection by the mixed muscarinic/σ1 ligand anavex2-73, a tetrahydrofuran derivative, in aβ25-35 peptide-injected mice, a nontransgenic alzheimer's disease model [53] differential contributions of apoe4 and female sex to bace1 activity and expression mediate aβ deposition and learning and memory in mouse models of alzheimer’s disease [54] alzheimer’s disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: an exploratory study [55] a systems view of the differences between apoe ε4 carriers and non-carriers in alzheimer’s disease [56] dysregulation of the hpa axis as a core pathophysiology mediating co-morbid depression in neurodegenerative diseases [57] a lentiviral sponge for mir-101 regulates ranbp9 expression and amyloid precursor protein metabolism in hippocampal neurons [58] trabalho de consenso de força-tarefa da wfsbp sobre marcadores biológicos das demências: contribuição da análise do lcr e do sangue para o diagnóstico precoce e diferencial das demências consensus paper of the wfsbp task force on biological markers of dementia: the role of csf and blood analysis in the early and differential diagnosis of dementia (world j biol psychiatry. 2005;6(2):69-84. review) [59] embodied cognition of aging [60] unique pharmacological property of isrib in inhibition of aβ-induced neuronal cell death [61] editorial: the metabolic-inflammatory axis in brain aging and neurodegeneration [62] jagged1 is altered in alzheimer's disease and regulates spatial memory processing [63] rey's auditory verbal learning test scores can be predicted from whole brain mri in alzheimer's disease [64] exosomes as carriers of alzheimer's amyloid-ß [65] graph theoretic analysis of structural connectivity across the spectrum of alzheimer's disease: the importance of graph creation methods [66] tailored lighting intervention improves measures of sleep, depression, and agitation in persons with alzheimer’s disease and related dementia living in long-term care facilities [67] cerebral microbleeds: a review of clinical, genetic and neuroimaging associations [68] nsaids may protect against age-related brain atrophy [69] the porphyromonas gingivalis/host interactome shows enrichment in gwasdb genes related to alzheimer's disease, diabetes and cardiovascular diseases [70] control of intracellular calcium signaling as a neuroprotective strategy [71] the neural correlates of unsuccessful memory performance in mci [72] polysaccharides from ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of alzheimer's disease [73] global analysis of ginsenoside rg1 protective effects in β-amyloid-treated neuronal cells [74] all in the family: how the apps regulate neurogenesis [75] nutrition, frailty, and alzheimer's disease [76] can insulin signaling pathways be targeted to transport aβ out of the brain? [77] comparison of the effects of transdermal and oral rivastigmine on cognitive function and eeg markers in patients with alzheimer's disease [78] automated spatial brain normalization and hindbrain white matter reference tissue give improved [18f]-florbetaben pet quantitation in alzheimer´s model mice [79] histamine h3 receptor inverse agonists on cognitive and motor processes: relevance to alzheimer’s disease, adhd, schizophrenia and drug abuse [80] regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (trem2) [81] the anti-inflammatory effects of lipoxygenase and cyclo-oxygenase inhibitors in inflammation-induced human fetal glia cells and the aβ degradation capacity of human fetal astrocytes in an ex vivo assay [82] prevalence of dementia subtypes in a developing country: a clinicopathological study [83] hsv-1 and alzheimer’s disease: more than a hypothesis [84] Improving predictive models for Alzheimer’s disease using GWAS data by incorporating misclassified samples modeling [85] Urine dicarboxylic acids change in pre-symptomatic Alzheimer’s disease and reflect loss of energy capacity and hippocampal volume [86] Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia [87] Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy [88] Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer’s disease differ according to disease severity and amyloid positivity [89] A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer’s disease [90] Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s disease [91] C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease [92] Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic [93] Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons [94] Inhibition of the ubiquitin-proteasome system in Alzheimer's disease [95] Astrocyte senescence promotes glutamate toxicity in cortical neurons [96] The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data [97] Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer’s disease [98] 16 Clinical course and the neglected half of Alzheimer's disease (AD) [99] Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients [100] What’s not in the news headlines or titles of Alzheimer disease articles? #InMice [101] Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis